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Abstract
Variation in personality traits is 30% to 60% attributed to genetic influences. Attempts to unravel
these genetic influences at the molecular level have, so far, been inconclusive. We performed the
first genome-wide association study of Cloninger’s temperament scales in a sample of 5117
individuals, in order to identify common genetic variants underlying variation in personality.
Participants’ scores on Harm Avoidance, Novelty Seeking, Reward Dependence, and Persistence
were tested for association with 1,252,387 genetic markers. We also performed gene-based
association tests and biological pathway analyses. No genetic variants that significantly contribute
to personality variation were identified, while our sample provides over 90% power to detect variants
that explain only 1% of the trait variance. This indicates that individual common genetic variants of
this size or greater do not contribute to personality trait variation, which has important implications
regarding the genetic architecture of personality and the evolutionary mechanisms by which heritable
variation is maintained.
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Introduction
Personality generally refers to those characteristics of the person that account for consistent
patterns of feeling, thinking, and behaving (Pervin, Cervone, & John, 2005). Modern
personality research focuses primarily on personality traits – dimensions of variation between
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individuals that are relatively stable over time and predict behaviour in various domains. The
most prominent taxonomy of personality traits, the ‘Big Five’, is based on atheoretical factor
analyses of self-descriptions. An alternative taxonomy, developed by Cloninger (Cloninger,
1986, 1987), aims to reflect the psychobiological etiology of personality. This model is
purportedly based on empirical findings from genetic research, studies of longitudinal
development, and psychometric studies of personality structure, as well as
neuropharmacological and neuroanotomical studies of behaviour and learning (Cloninger,
1986). The model is widely utilised, although some studies have revealed psychometric
limitations (Farmer & Goldberg, 2008) or failed to find support for the structure of the model
at the biological or psychological level (Herbst, Zonderman, McCrae, & Costa, 2000).
Cloninger’s model originally consisted of three dimensions of personality (temperaments):
Novelty Seeking, Harm Avoidance, and Reward Dependence, measured by the Tridimensional
Personality Questionnaire (TPQ; Cloninger, 1986; Cloninger, Przybeck, & Svrakic, 1991).
Reward Dependence originally included items measuring persistence, but the persistence items
were later revealed to be uncorrelated with other Reward Dependence items; in a revised model,
Persistence was designated as a fourth dimension of temperament (Cloninger, 1994). Although
Cloninger also extended his model with three additional character (aspects of self concept)
dimensions, measured by the Temperament and Character Inventory (TCI), we focus here on
the four dimensions of temperament. Correlations between the different temperament scales
are low and principal components analysis identifies each temperament as a separate factor
(Cloninger, Svrakic, & Przybeck, 1993; Keller, Coventry, Heath, & Martin, 2005).
The four temperament dimensions of the psychobiological model are hypothesised to be
associated with genetically independent neurobiological systems. Individual differences on
these dimensions are thought to be the basis of individual variation in personality (Cloninger,
1986). Novelty Seeking reflects the tendency to respond strongly to novelty and cues for reward
as well as relief from punishment, and is thought to play a role in the activation or initiation of
behaviours. Harm Avoidance reflects the tendency to respond strongly to aversive stimuli,
which leads to learned inhibition of behaviour, and is thought to play a role in the inhibition
or ceasing of behaviours. Reward Dependence reflects the tendency to react strongly to rewards
and to maintain behaviours previously associated with reward or relief of punishment, and is
thought to play a role in the maintenance or continuation of behaviour (Cloninger, 1986,
1987). Persistence reflects the tendency to persevere despite frustration and fatigue (Cloninger,
et al., 1993).
Based on evidence from physiopsychological and animal studies, variation in the temperament
dimensions is thought to be influenced by activity in specific neurotransmitter pathways
(Cloninger, 1986, 1987) – Novelty Seeking by dopaminergic activity, Harm Avoidance by
serotonergic activity, and Reward Dependence by noradrenergic activity. Gerra et al. (2000)
found that individual’s hormonal response to specific neurotransmitter agonists correlated with
TPQ scale scores in accordance with Cloninger’s theory, but further evidence is needed to
support the relationship between the different neurotransmitter pathways and Cloninger’s
temperament scales.
As Cloninger (1987) predicted, scores on certain TPQ/TCI scales are associated with specific
problem behaviours and psychological disorders, including depression, anxiety, bipolar
disorder, obsessive compulsive disorder, conduct disorder, alcohol and drug dependence,
criminal behaviour and antisocial personality disorder (Ettelt, et al., 2008; Howard, Kivlahan,
& Walker, 1997; Khan, Jacobson, Gardner, Prescott, & Kendler, 2005; Mulder, Joyce,
Sullivan, Bulik, & Carter, 1999; Nery, et al., 2008; Nery, et al., 2009; Ongur, Farabaugh,
Iosifescu, Perlis, & Fava, 2005). Thus, the temperament scales are potential endophenotypes
for these behaviours and disorders. An endophenotype is a more basic, heritable, underlying
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quantitative trait, which more directly reflects the influence of the genome (Gottesman &
Gould, 2003).
Heritability estimates for the TPQ/TCI scales range from approximately 30% to 60%
(Gillespie, Cloninger, Heath, & Martin, 2003; Gillespie, Johnstone, Boyce, Heath, & Martin,
2001; Heath, Cloninger, & Martin, 1994; Heiman, Stallings, Hofer, & Hewitt, 2003; Keller,
et al., 2005), consistent with heritability estimates for other personality scales such as the Big
Five (Jang, Livesley, & Vernon, 1996) and Eysenck’s personality dimensions (Keller, et al.,
2005; Zietsch, Verweij, Bailey, Wright, & Martin, 2010). Despite these substantial genetic
influences, identifying the specific genetic variants underlying individual differences on TPQ/
TCI and other personality scales has proved difficult.
Genetic linkage and candidate gene association studies on personality have yielded mixed
results. Linkage studies test for coinheritance of genetic markers and traits within families.
There have been various linkage findings for the different personality scales, including
Neuroticism (Kuo, et al., 2007; Neale, Sullivan, & Kendler, 2005; Wray, et al., 2008), Harm
Avoidance (Cloninger, et al., 1998), Novelty Seeking (Curtis, 2004), Psychoticism and
Extraversion (Gillespie, et al., 2008), but none have been consistently replicated. Candidate
gene association studies test for a correlation in the population between scores on a personality
scale and a specific genetic variant with a known function that could relate to personality. The
two most extensively studied candidate genes are the dopamine D4 receptor gene DRD4 and
serotonin transporter gene SLC6A4. Several studies have found association between a variant
of the dopamine D4 receptor gene and Novelty Seeking (Benjamin, et al., 1996; Ebstein,
Nemanov, Klotz, Gritsenko, & Belmaker, 1997; Ebstein, et al., 1996), and between a
polymorphism (5-HTTLPR) in the promoter region of the serotonin transporter gene and
anxiety-related traits like Harm Avoidance (Lesch, et al., 1996; Vormfelde, et al., 2006).
However, other studies were unsuccessful in replicating these associations (i.e., Becker, El-
Faddagh, Schmidt, & Laucht, 2007; Ebstein, Gritsenko, et al., 1997; Herbst, et al., 2000; Lang,
et al., 2004; Malhotra, et al., 1996). A recent meta-analysis (Munafo, Yalcin, Willis-Owen, &
Flint, 2008) concluded that the DRD4 gene (C-521T polymorphism) may be associated with
Novelty Seeking and Impulsivity, explaining up to 3% of the phenotypic variance, but that
publication bias may have distorted the findings. Another meta-analysis (Munafo, et al.,
2009) found no significant association of the 5-HTTLPR genotype with Harm Avoidance or
Eysenck’s Neuroticism scale, but they did report a significant association with the NEO
Neuroticism scale. Two more recent large studies provided further mixed evidence, with one
reporting no association of 5-HTTLPR with Neuroticism (Terracciano, et al., 2009), and the
other finding a significant association with Neuroticism but not Harm Avoidance (Wray, et al.,
2009).
Recent technological advances have enabled genome-wide association (GWA) studies. Here,
single nucleotide polymorphisms (SNPs) across the entire genome are systematically tested
for association with a given trait. The approach is considered “hypothesis-free” since no prior
knowledge of gene function is considered. GWA studies have been successful in identifying
some genetic variants underlying disease traits (Burton, et al., 2007; Visscher & Montgomery,
2009). They have also had some success in identifying genetic variants associated with smoking
(e.g. LiuTozzi, et al., 2010), and with complex mental disorders including schizophrenia (Shi,
et al., 2009; Stefansson, et al., 2009; The International Schizophrenia Consortium, 2009),
bipolar disorder (The International Schizophrenia Consortium, 2009), and autism (Wang, et
al., 2009). However, despite the high heritability of these disorders and traits, the identified
genetic variants have been of very small effect (<1% of variance accounted for) and the
aggregate effect of all the individual variants only accounts for a few percent of the trait
variance, at most.
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It is now thought that the genetic architecture of mental disorder is very complex, and may be
difficult to resolve using standard GWA approaches (Manolio, et al., 2009; The Psychiatric
GWAS Consortium Steering Committee, 2009). In particular, Keller and Miller (2006) argue,
based on evolutionary genetic theory and empirical evidence, that mental disorder is likely to
be due to the aggregate effect of many mildly harmful rare mutations, impossible to detect with
standard GWA studies. However, using similar evolutionary genetic theory, Penke, Dennison
and Miller (2007) argue that personality traits are likely to be under balancing selection, and
therefore influenced by a limited number of common genetic variants of medium effect. If this
is true, personality may be an ideal psychological trait to attack with the GWA approach.
Early evidence has been mixed. There have been three published GWA studies on personality
traits - two on Neuroticism and one assessing all Big Five traits. Van den Oord et al. (2008)
found potential association between variants in the MAMDC1 gene and Neuroticism, and
Shifman et al. (2008) found suggestive association between the PDE4D gene and Neuroticism,
which was replicated in one sample, but failed to replicate in two other samples. Terracciano
et al. (2008) found potential association signals for all five scales, but the effect sizes were
small and most of the associations failed to replicate in their follow-up samples. GWA has yet
to be applied to Cloninger’s temperament scales, which could better reflect genetic influences
given their purported basis in psychobiological experiments and theory.
In a sample of 5117 Australians of European ancestry from 2567 families, we perform the first
GWA study of Cloninger’s temperament scales, in order to identify common genetic variants
associated with individual differences in personality. Identification of genetic variants
underlying personality traits might also broaden our understanding of behavioural and
psychiatric disorders related to personality. On the other hand, if we do not detect any genetic
variants that explain a substantial part of the variance in these traits, this would have strong




Health and Lifestyle Questionnaires were sent to two cohorts of Australian twins and their
families (parents, children, spouses and siblings), the first in 1988 and the second in 1990. The
total number of participants was over 27,000, with an age range of 17 to 96 (M = 39.7, SD =
15.3). Phenotypic data on the TPQ were available for 20,464 individuals, of which 5117 (1727
males and 3390 females) from 2567 independent families were genotyped. Phenotypic and
genotypic data collection was approved by the Queensland Institute of Medical Research
(QIMR) Ethics Committee and informed consent was obtained from all participants. More
details about the phenotypic data collection can be found elsewhere (Heath, et al., 1994; Keller,
et al., 2005).
Personality measures
A short version of the original TPQ was included as part of the Health and Lifestyle
Questionnaire. Although the TPQ originally measured only three dimensions, subsequent
revisions of the measure resulted in the addition of an extra dimension, Persistence. As such,
we analysed five items that originally contributed to Reward Dependence as a separate
Persistence scale. Additionally, after revision of the scale, one of the Reward Dependence items
was assigned to Novelty Seeking. Our final personality measure included 18 Harm Avoidance,
19 Novelty Seeking, 12 Reward Dependence, and 5 Persistence items.
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Each item could be answered with a true/false response and to avoid response set bias the items
were phrased in such a way that for some items a true and for others a false answer adds to the
subscale score. Scale scores were calculated by summing the item scores for each scale. For
the complete sample (i.e. including the non-genotyped individuals), we then performed the
following data preparation procedure. Missing items were replaced with the sample mean score
on the specific item. Individuals with missing values on more than 25% of the scales’ items
were treated as missing for that scale. Scale scores were then transformed by taking the arcsine
of the square root, in order to minimize departures from normality (Eaves, Eysenck, & Martin,
1989; Freeman & Tukey, 1950). Finally, scores were corrected for age, age2, sex, sex*age, and
sex*age2 effects and all scales were standardised separately for each sex to a mean of 0 and a
standard deviation of 1.
Previous behaviour genetic analyses of the twins and siblings in our phenotypic sample
indicated broad heritability estimates of 45% and 42% for Novelty Seeking, 40% and 40% for
Harm Avoidance, 35% and 38% for Reward Dependence and 35% and 35% for Persistence,
for males and females respectively, with remaining variance explained by unshared
environmental influences (Keller, et al., 2005). Note that Keller et al. (2005) analysed one item
as contributing to the Reward Dependence scale while we assigned it to the Novelty Seeking
scale in accordance to the scales’ revision. For all temperament scales, reliability and internal
consistency were determined to be satisfactory to good in an earlier study using subsamples
of the complete phenotypic sample (Keller, et al., 2005). The 2.1 year test-retest correlations
(as tested in 881 twins) was 0.79, 0.73, 0.68, and 0.64 for Harm Avoidance, Novelty Seeking,
Reward Dependence, and Persistence, respectively; Cronbach’s α (as tested in 7834 to 7862
twins and siblings) was 0.61, 0.68, 0.75, and 0.84 for Harm Avoidance, Novelty Seeking,
Reward Dependence, and Persistence, respectively. These reliability and internal consistency
values are in accordance with those reported in other TPQ/TCI studies (Cloninger, 1994;
Cloninger, et al., 1993).
In the same study on all twins and siblings in our phenotypic dataset evidence was found for
sex differences in the source of genetic variation for Harm Avoidance and Reward Dependence
(Keller, et al., 2005), implying that partly different genetic factors explain variance in these
scales for males and females. Therefore, for these two scales we ran the GWA analysis
separately for males and females, as well as for the sample as a whole.
Genotyping, quality control, and imputation procedures
The QIMR Genetic Epidemiology Laboratory has collected a wide range of phenotypic
variables and DNA samples as part of different projects. DNA samples were collected in
accordance with standard protocols and submitted to different genotype centres using different
SNP platforms (Illumina 317K, Illumina HumanCNV370-Quadv3, Illumina Human610-Quad,
and Affymetrix 6.0). The quality control (QC) procedure we employed for the combined use
of these Illumina and Affymetrix genotype data consisted of three steps (see Figure 1, Appendix
I). Initial QC control - including checks for ancestry outliers, Hardy Weinberg Equilibrium,
Mendelian errors, Minor Allele Frequency (MAF) - was applied separately to all different
projects. Full details of these initial QC procedures for the Illumina and Affymetrix data are
described in detail in Medland et al. (2009) and Wray et al. (submitted), respectively. As the
individuals genotyped on the Affymetrix platform comprised a sample of major depressive
disorder cases only, more stringent QC criteria were applied. We had 327 individuals
genotyped on both the Illumina and the Affymetrix platform, allowing for cross project QC.
These checks led us to a more stringent value (>0.02; using the Birdseed program) for the
genotype confidence score for the Affymetrix data for selecting which SNPs to include in our
dataset. After QC control of the individual projects, the data from the different Illumina projects
were combined and additional QC was applied to this combined dataset.
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The genotyped SNPs in common between the remaining Illumina (N=269,840) and Affymetrix
(N=646,601) SNPs were relatively few (N=137,768). Therefore, genome-wide association
analyses of the combined data could only be conducted using imputed genotypes. After initial
QC checks, both datasets were imputed separately by MACH (Abecasis, unpublished) using
the data from the European HapMap 1+2, Release 22 Build 36. Only SNPs with an imputation
quality score (R2) greater than 0.3 were retained, which resulted in a total number of 2,380,486
imputed Illumina and 2,369,130 imputed Affymetrix SNPs.
SNPs were retained for analysis only if imputed successfully on both platforms, had a MAF >
0.01, and had high concordance in best-guess genotypes for the 327 individuals imputed twice
(from Affymetrix and Illumina genotypes; the family-based association analysis requires use
of best-guess genotypes). Specifically, high concordance was measured as discordance/
heterozygosity > 0.04, where discordance is the proportion of individuals with discordant
genotypes and heterozygosity = 2*MAF*(1-MAF), and MAF is the minor allele frequency
estimated from the Illumina imputed set. The correction for heterozygosity removes the
dependence of discordance rate on MAF. In total, 1,252,387 SNPs were available for
association analyses, representing SNPs that are strongly validated for all samples. After QC,
if only one individual from a monozygotic twin pair had been genotyped, the non-genotyped
co-twin was assigned that genotype as well. The final genotyped sample in this study included
5117 individuals from 2567 families, including 797 monozygotic (MZ) twin pairs (1702 MZ
twin individuals), of which 680 MZ individuals were assigned their cotwin’s genotype.
Statistical analyses
After imputation and quality control, the combined genotypic dataset consisted of 1,252,387
SNPs. The best guess genotype at each SNP was tested for association with the four TPQ scales
using the family-based association test as implemented in Merlin (-fast-assoc, Chen &
Abecasis, 2007), which accounts for family relationships including MZ twins. The additive
genetic effect was calculated, in which the genotypic mean of the heterozygote (Aa) was
modelled as the average of the two homozygotes (AA, aa). Because sex differences in the
source of genetic variance have been found for Reward Dependence and Harm Avoidance, we
also performed the association test for these variables for males and females separately.
Association analyses of genotyped markers on the X-chromosome was conducted using Minx
(as implemented in Merlin). Because the imputation software did not support sex
chromosomes, SNPs at the X-chromosome are not imputed; the association analyses only
included those SNPs that have been genotyped for at least 85% of the sample (N=7526).
Association between a SNP and a phenotype is generally accepted to be genome-wide
significant at α = 0.05 if the p value is 7.2*10−8 or smaller, as this corrects for the total number
of independent tests (Dudbridge & Gusnanto, 2008). We performed eight separate association
analyses, so declared significance level at 9.0*10−9 (7.2*10−8/8).
In order to determine if there are genes which harbour an excess of associated variants, we
conducted a gene-based test (VEGAS) that can be used for GWAS with related individuals
(Liu, McRae, et al., 2010). Genes are functional groups of nucleotides that code for proteins.
The test summarises evidence for association on a per gene basis by considering the p-value
of all SNPs within genes (including +/−50kb from the 5′ and 3′ UTR), while accounting for
linkage disequilibrium (LD) and number of SNPs per gene1. The gene-based test identifies
genes which show more signal of association than expected by chance given their length and
LD between the SNPs. As such it tests for a different genetic architecture of genes than single
SNP tests. The relevance of the gene-based test depends on the underlying genetic architecture
of genes which is unknown and which is expected to differ between genes. Because we perform
eight gene-based association tests each including 17,206 autosomal genes, we consider genes
with a p-value below α = 3.6*10−7 (0.05/(8*17,206)) to be significant.
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To detect underlying biological pathways of importance to personality, all genes with an
empirical p value below p = 0.01 were included in a pathway analysis using the Ingenuity
Pathway analysis program (Ingenuity Systems, release IPA 6.0). The Ingenuity database
contains large amounts of up-to-date information (based on scientific publications) about the
localisation, structure and biological function of proteins and their interactions. By means of
pathway analysis it is possible to check whether the genes most associated with personality in
our gene-based test are more prevalent in any known biological or canonical pathway than
would be expected by chance. We set the alpha level at 0.01 and p-values for each pathway
were corrected by the Benjamini-Hochberg multiple testing correction as implemented in
Ingenuity. We used an alpha level of 0.01 rather than 0.05 to account for the multiple traits
testing.
Statistical power
It is expected that many genes of very small effect size contribute to the genetic variance of
complex behavioural phenotypes like personality. We estimated the empirical power our
sample provides to detect genetic variants explaining 1% and 0.5% of the phenotypic variance
by running association tests on simulated datasets in Merlin. The simulated datasets that are
generated are similar to the original data in terms of marker informativeness, allele frequency,
trait distribution, and missing data patterns, but original phenotypic values and individual’s
genotypes for a selected SNP are replaced. The selected SNP is simulated such that it accounts
for a specified proportion of the variance. The Merlin command we used is ‘--simulate --
trait [variable name],[SNPname],0.01,0.39,0.60’, implying that the marker accounts for 0.01
of the phenotypic variance for a trait with a heritability of 0.40. The selected SNP we choose
had a minor allele frequency of 0.25. For more information about the simulation procedure see
http://www.sph.umich.edu/csg/abecasis/Merlin/reference/simulation.html.
Association analysis was conducted on 1000 data sets generated by the simulation procedure.
The empirical power is estimated as that proportion of the 1000 association analyses in which
a genome-wide significant association (α = 7.2*10−8) was detected. Results indicated that our
sample provides 91.5% power to detect SNPs that explain 1% of the variance in the personality
traits, and 26.2% power to detect SNPs that explain 0.5%.
Results
The average age of the genotyped sample is 34.7 years (SD=11.1) for males and 36.9 years
(SD=12.5) for females. Older participants of both sexes scored lower on Novelty Seeking.
Male and female means for the four temperament scales are shown in Table 1. In accordance
to earlier findings (e.g., Stallings, Hewitt, Cloninger, Heath, & Eaves, 1996), females score
higher on the Harm Avoidance and Reward Dependence scales, while males score slightly
higher on Novelty Seeking and Persistence. The scales were therefore adjusted for sex and age
effects and their interactions for the subsequent association analyses.
We tested 1,252,387 SNPs for association with four personality scales; Harm Avoidance,
Novelty Seeking, Reward Dependence and Persistence. The Quantile-Quantile (QQ) plots for
1The SNPs considered for each gene are those in a gene or within ±50kbs of a gene’s 5′ and 3′ UTRs. For a given gene with n SNPs,
association p-values are first converted to chi-squared 1-df statistics. The gene-based test statistic is then the sum of all the chi-squared
1-df statistics within that gene. The test uses multivariate normal simulations to model the LD structure of SNPs within genes using the
HapMap2 CEU genotypes, and therefore assumes that the LD structure in the European CEU sample is representative of our sample. To
account for linkage disequilibrium, correlated chi-squared 1-df random variables can be generated for n SNPs by simulating an n-element
multivariate normal vector with mean 0 and covariance matrix the n×n r SNP correlation matrix. The sum of all the squared elements
will then have the same approximate distribution as the gene-based test statistic under the null hypothesis. Thus, an empirical gene-based
p-value can be estimated by comparing the observed gene-based test statistic with those from a large number of multivariate normal
simulated vectors.
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each scale, illustrating the observed p-values for the autosomal associations in relation to the
expected p-values (based on the number of tests, under the null hypothesis of no association),
are presented in Figure 2. Lambda (a measure for quantifying population stratification effects)
for all variables is close to 1, indicating the residual population stratification effects are
minimal. For three of the four scales we found fewer extremely low (at the very low end of the
distribution) p-values than expected by chance. We checked whether this was due to the fact
we use family data by running a GWAS with only independent individuals in Merlin as well
as in PLINK (Purcell, et al., 2007). We also checked whether it was due to high LD between
SNPs by testing only independent SNPs in Plink. The QQ-plots from these analyses did not
differ markedly from the original analyses.
Results of our association analyses are shown in Figure 3. The lack of data points near the top
of each panel (i.e. p ≈ 10−8) indicates that there were no strong association signals. SNPs in
the top 50 with lowest p-values for each temperament scale are presented in Table 2 (excluding
redundant SNPS that are in high LD (r2 > .70) with more significant SNPs).
No SNPs reached genome wide significance (α = 7.2*10−8) and the SNP with the lowest p-
value for each personality scale explains less than 0.5% of the total variance. Also, the results
for the sex-specific association tests for Harm Avoidance and Reward Dependence did not
provide any genome-wide significant results (see Supplementary Table, S1), nor did the
association tests on the genotyped SNPs on the X-chromosome. The top associated SNPs in
the sex-specific analyses explained a higher percentage of the variance (up to almost 2% for
males) than those in the full sample, a result that may support sex-specific effects. However,
this result should be viewed with caution since smaller samples tend to overestimate the
variance explained by the top SNPs (‘the winner’s curse’; Zhong & Prentice, 2010).
We examined whether any of the 50 SNPs with the lowest P-value for each scale were in or
close to a gene of known relevant function. None of the top SNPs were previously related
directly to personality. However, one of the top SNPs (rs10176705) for Novelty Seeking was
located intronic to NRXN1, a gene previously found to play a role in neuropsychiatric
disorders, including schizophrenia (Kirov, et al., 2009), autism (Glessner, et al., 2009), nicotine
dependence (Nussbaum, et al., 2008), and with cognition (Need, et al., 2009). In our gene-
based test the NRXN1 gene had a p-value of .01 (ranked 441). In the top 50 for Harm Avoidance
in females, a SNP located intronic to ROBO-2 was previously suggestively associated with
schizophrenia (Potkin, et al., 2009) and a SNP intronic to MCTP1 was suggestively associated
with bipolar disorder (Scott, et al., 2009). Further, a SNP close to GABRG3 found for Reward
Dependence in females showed suggestive association with alcohol dependence before (Dick,
et al., 2004).
In the gene-based test, no genes reached significance (α = 3.6*10−7, see Table 3). The most
notable result from the gene-based test was the top ranking of the axonal guidance gene SLIT2
for reward dependence (p = 2.8*10−5), a gene that has previously been associated with anger
in suicide attempters (Sokolowski, Wasserman, & Wasserman, 2010).
Next we tested whether genes with the strongest association signals were concentrated in
known biological or canonical pathways. We performed biological pathway analyses including
all genes with a p-value below .01 - this included 304 genes (1.8%) for Harm Avoidance, 351
genes (2.0%) for Novelty Seeking, 276 genes (1.6%) for Reward Dependence, and 279 genes
(1.6%) for Persistence. Results indicated that our top genes were not significantly more
prevalent in any known biological or canonical pathway.
Finally, we examined evidence for association in our sample for candidate genes and SNPs
published in earlier association studies of personality, including the serotonin receptor gene
(SLC6A4), the dopamine D4 receptor gene (DRD4), and SNPs and genes reported in previous
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GWA studies on personality (Shifman, et al., 2008; Terracciano, et al., 2008; van den Oord,
et al., 2008). There have been no previous GWA studies on Cloninger’s scales, but there is
substantial overlap between Cloninger’s scales and the Big Five/Eysenck’s scales. Based on
inter-scale correlations reported in de Fruyt et al. (2000), we looked for overlapping signals in
the following groups: Neuroticism (Harm Avoidance), Extraversion and Openness (Harm
Avoidance, Novelty Seeking, and Reward Dependence), and Conscientiousness (Harm
Avoidance, Novelty Seeking, and Persistence).
No SNPs (or if not available, proxies in high LD) with previously reported associations were
even nominally significant (p < .05) in our data. Note that not all SNPs mentioned in earlier
studies were available in our dataset. A SNP in the gene CDH23 was listed by Terraciano et
al. (2008) in association with Extraversion (p = 1.1*10−5); this gene had a gene-based
association p-value with Novelty Seeking of .002 in our study. However, the gene effect was
not significant in their study, and absent in the replication samples in their own study. None
of the other genes were nominally significant in our data - in particular the DRD4 (Novelty
Seeking) and SLC6A4 (Harm Avoidance) genes had p-values of 0.32 and 0.65, respectively.
We calculated that our SNPs captured 52% of the variance in the DRD4 gene and 80% of the
variance in the SLC6A4 gene. We did this by identifying the overlap between our SNPs and
all SNPs within 50kb of the genes (as per HapMap Genome Browser) and then calculating
what proportion of the total variance of the gene our SNPs covered using the Tagger option in
Haploview (selecting SNPs with a MAF > 0.05 only).
Discussion
We performed the first genome wide association analysis on the Cloninger temperament scales
Harm Avoidance, Novelty Seeking, Reward Dependence, and Persistence in a population
sample of 5117 people from 2567 families. Although we had over 90% power to detect SNPs
accounting for 1% of the variance in the scales, we detected no genome-wide significant SNPs
for any scale. The SNPs in our dataset (including imputed SNPs) account for the vast majority
of the common genetic variation in the population (Frazer, et al., 2007). Moreover, although
we only had 26% power to detect common variants that account for 0.5% of the variance, if
such variants comprised only half of the genetic variation for each trait, 40 such variants would
be implied for a trait with heritability of 40%, implying that ten (i.e. 0.26*40) such variants
should have been detectable per trait, yet we detected none across all traits. Therefore, our
results suggest that the genetic architecture of personality consists of either very many common
variants of very small effect size or rare variants (not tagged in our SNP chips), or both.
These results are consistent with those from previous GWA studies on Eysenck’s Neuroticism
scale (Shifman, et al., 2008) and the Big Five personality traits (Terracciano, et al., 2008), and
prior genome-wide linkage studies on personality scales, which have failed to identify any
consistently replicable genome-wide significant variants. However, the (lack of) results in
genome-wide searches contrast with some earlier candidate gene studies that found association
of DRD4 and SLC6A4 with Novelty Seeking/Extraversion and Harm Avoidance/Neuroticism,
respectively (e.g., Benjamin, et al., 1996; Ebstein, 2006; Vormfelde, et al., 2006). Tellingly,
these two genes showed no association at all with the corresponding scales in the present study
despite the very large sample size, consistent with more recent evidence against a link between
these genes and personality (Munafo, et al., 2009; Terracciano, et al., 2009).
Some of our top SNPs and genes were located in or near genes previously associated with other
psychological traits, but none were directly related to personality. Our top genes did not overlap
more than expected by chance with known functional molecular pathways. Furthermore, none
of our top SNPs corresponded with the top SNPs in Terraciano et al. (2008), Shifman et al.
(2008) and van den Oord et al. (2008) for overlapping Big Five/Eysenck scales (e.g., Harm
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Avoidance and Neuroticism, Novelty seeking and Extraversion); indeed, none of the top SNPs
in those studies were even nominally significant (p < .05) in our data. This strongly reinforces
the conclusion that, individually, common genetic variants do not contribute substantively to
variation in personality.
This raises the question of ‘missing heritability’: if personality is heritable with 30–60% of the
variance explained by genetic effects, why can we not find any specific genetic variants to
account for that heritability? Missing heritability has been observed to a large extent in almost
all complex traits (Maher, 2008). Proposed explanations focus on: many variants of very small
effect that are yet to be found; rare variants that are poorly detected by available genotyping
arrays that focus on variants present in at least 5% of the population; structural variants poorly
captured by existing arrays, such as copy number variations; and low power to detect epistasis
(interaction between genes) (Manolio, et al., 2009). Newer technologies (e.g. whole genome
sequencing) and novel statistical approaches combined with larger samples and meta-analyses
will contribute to our understanding of the genetic architecture of complex traits.
A robust theoretical framework could also help to gain a fuller understanding of the genetic
basis of complex traits. In this vein, Penke, Denisson and Miller (2007) provided an
evolutionary framework for relating the genetic architecture of personality traits to the selective
pressures they have been under. Penke et al. argued that personality traits are most likely to
have been under balancing selection by environmental heterogeneity (i.e. different selective
pressures in different environments), often mediated by negative frequency-dependent
selection (another form of balancing selection, where a phenotype is advantageous only when
it is rare in the population). According to evolutionary genetic theory, traits under balancing
selection should be influenced by a relatively limited number of common genetic variants with
medium effect sizes (Barton & Keightley, 2002; Penke, et al., 2007; Roff, 1997). However,
our findings falsify this prediction, since no individual common genetic variants account for
more than half a percent of personality trait variation in our data. This suggests that personality
variation is likely to be maintained by a mechanism other than balancing selection. One
possibility is selective neutrality, where personality differences make virtually no difference
at all to fitness in any environments. Penke et al. argue that this is implausible, given the
pervasive importance of personality differences in social and romantic relationships among
other things, but it ultimately depends on the correlation between the net effect of a specific
genetic variant (across potentially multiple pleiotropic functions) and total fitness. The other
possible mechanism for maintaining genetic variation is mutation-selection balance. In
mutation-selection balance, the appearance of new mutations is balanced by purifying
selection, which eliminates deleterious mutations. The time lag of purifying selection means
all individuals carry a load of mildly deleterious mutations that have yet to be eliminated by
selection2. Trait variation corresponds to variation in individuals’ mutation load. Traits under
mutation-selection balance are expected to be influenced by very many rare genetic variants
of small effect (Keller & Miller, 2006; Penke, et al., 2007; Zhang & Hill, 2005). This is not
inconsistent with the present results, since GWA studies are unable to detect rare genetic
variants of small effect (Manolio, et al., 2009).
In mutation-selection balance explanations, there is an optimal adaptive ‘design’ that is the
product of selective processes that maximise fitness. Accumulated random mutations are likely
to have pleiotropic downstream effects that disrupt this design, deteriorating fitness in various
ways (Keller & Miller, 2006; Zhang & Hill, 2005). The deleterious effects of mutation load
will be especially apparent in mental functioning, since the brain has such a large mutational
target size (over half of the genome is probably expressed in the brain; Sandberg, et al.,
2Selection quickly eliminates mutations with the largest and most dominant harmful effects due to non-viability or infertility of the
organism, so mutation loads consist largely of mildly harmful recessive mutations (Keller & Miller, 2006).
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2000). This lends itself well to explaining psychiatric disorders, where normal mental
functioning is thought to be disrupted by mutation load to the point of drastic dysfunction
(Keller & Miller, 2006). It is less clear how mutation load might manifest in traditional
personality traits, since they have not generally been considered in the context of good scores
(high fitness) or bad scores (low fitness) (Almagor, Tellegen, & Waller, 1995; Zietsch,
2009).
However, variation on Cloninger’s scales seems very likely to relate to fitness. For example,
it is hard to imagine that individuals’ propensity to avoid harm (Harm Avoidance) would be
unrelated to their survival and reproductive prospects. Very low levels of Harm Avoidance
would lead to greater chance of injury or death, but very high levels would lead to excessive
timidity that would likely impair survival and mate acquisition, especially in animals or in
human hunter gatherer societies. Thus the ‘optimal adaptive design’ would be an intermediate
level of Harm Avoidance, and the same could be argued for Novelty Seeking, Reward
Dependence, and Persistence. In this scenario (stabilising selection), a mutation-selection
balance explanation would involve high mutation loads disrupting the optimal design and being
associated with maladaptive high and low extremes of each Cloninger personality scale.
Purported indicators of mutation load such as fluctuating asymmetry and low intelligence
(Gangestad & Yeo, 2006; Keller & Miller, 2006; Prokosch, Yeo, & Miller, 2005) would be
expected to show a curvilinear (U-shaped) relationship with the scales. The offspring of
relatives, being homozygous at more genetic loci and more likely to express the full effects of
harmful recessive mutations, would be expected to have more extreme Cloninger scale scores
(i.e. inbreeding depression should be associated with increased scale variance). Future research
should test these predictions, and the research should include animal studies, especially given
that Cloninger’s scales were developed in part using mouse models.
The present results, in combination with previous findings, indicate that variants of moderate
or large effect do not play a role in variation in personality in the population - if they did, GWA
studies should have found the common variants, and linkage studies should have found rare
variants. This narrows the search to common and rare variants of small effect. Current GWA
methods with increasingly large sample size will enable identification of common variants of
ever-smaller effect size. However, current methods do not allow investigation of accumulated
rare variants of small effect, which may play a substantial role in personality and other traits.
A key challenge is to develop genotyping technologies and statistical approaches for
quantifying mutation load across the genome (e.g. how many mutations (very rare alleles) an
individual’s genome contains). In this regard, the dual problem with current GWA methods is
that 1) rare variants are not included on SNP chips, and 2) the rarer a variant is, the less reliably
the genotype can be determined. Whole genome sequencing, which will become feasible in
large samples in the near future, has the potential to address these problems and greatly
accelerate investigation of the effects of accumulated mutations (Morris & Zeggini, 2010), but
will require large sample sizes.
In summary, the failure to find common genetic variants underlying Cloninger’s
psychobiological temperament scales accords with previous studies that have failed to find
common variants underlying Eysenck’s Neuroticism and the Big Five personality scales. That
individual common genetic variants which explain 0.5% or more of the variance do not
substantially affect personality has important implications for our understanding of its genetic
architecture.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Summary information of the Quality Control procedure of the genotype data. Shown are the
cut-offs for dropping SNPs or individuals from the dataset.
MAF=Minor allele frequency, HWE=Hardy Weinberg Equilibrium, SNPs=Single Nucleotide
Polymorphism, * using the Birdseed v2 algorithm as implemented in the BirdSuite software
(Korn, et al., 2008), **as implemented in PLINK mishap test (Purcell, et al., 2007).
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Q-Q plots of observed and expected −log10(P) of the associations between SNPs and the four
personality scales. Grey areas represent 95% confidence intervals.
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Results of the genome-wide association analyses for Cloninger’s personality scales. The x-axis
shows the chromosome numbers and the y-axis the significance of the association signals (i.e.
−log10(P) value).
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